This document starts from the observation that in tandem with rapid advances in biotechnology research having valuable applications for use in healthcare the Canadian technology transfer activity has grown significantly.
In order to assist its researchers in providing this information, KU Leuven Research & Development (technology transfer office of KU Leuven) has developed a mandatory Patent Inventor Form.
PROvendis has its origins in the innovation consulting firm Zenit GmbH. Founded in 1984, ZENIT is a Public Private Partnership owned by the State of North Rhine- Westphalia, a consortium of banks and an association comprising some 180 enterprises.
More and more innovation is driven by research collaborations between different entities. Within the context of globalized economy, these research and innovation collaborations are becoming increasingly internationalised.
This presentation provides an overview of the elements generally considered by each of the parties involved in the discussion on the relative value of the transferred intellectual property and know how at the time of the incorporation of a start-up company.
The NMBU Technology Transfer (NMBU TTO) was established in 2004 to create value from good ideas and research results from Norwegian Institute of Life Sciences. Unlike many other TTOs in Norway, the TTO at NMBU is an internal unit that belongs to the Research Department.
Copenhagen University Hospital is a conglomerate of several hospitals in the region, together with the Faculty of Health and Medical Sciences at the University of Copenhagen. The Hospital has 5 strategic research areas, and a clinical research centre.
Have you ever wondered if you (or your research team) ever invent something that has direct translational value what steps will be necessary to actually bring it out in the market?
Technology licensing is an activity where the owner of a patent (the licensor) allows another party (the licensee) the rights to use, adapt and commercialize that patent in exchange for compensation.
In designing new products and services, companies consider licensing technology as a means of getting to market quickly while reducing risk as well as the expenditure associated with the development stage.
Gathering and analyzing market data may be at the heart of developing the technology transfer strategy, but its value is not limited to the go/no-go decision and planning how to move forward.
So here is a list we’ve put together to ensure that the most important aspects of license negotiations stay front and center.
Join our newsletter and get the latest news